NeoBiotechnologies | Recombinant Monoclonal Antibodies for Cancer Research jobs and careers

About NeoBiotechnologies | Recombinant Monoclonal Antibodies for Cancer Research

NeoBiotechnologies | Original Manufacturer of Validated Monoclonal Antibodies NeoBiotechnologies is a biotechnology company based in the San Francisco Bay Area specializing in the development and manufacturing of highly validated monospecific monoclonal antibodies for cancer research and diagnostics. Founded by Dr. Atul K. Tandon, a pioneer in monoclonal antibody innovation and founder of NeoMarkers (now part of Thermo Fisher Scientific), NeoBiotechnologies was established to restore scientific rigor, reproducibility, and trust in antibody research. Unlike resellers, we are an original product manufacturer — every antibody in our catalog is developed, validated, and quality-controlled in-house. This end-to-end ownership allows us to ensure unparalleled specificity, consistency, and reproducibility, addressing a critical need in life science research where antibody reliability directly impacts data integrity. Our portfolio includes over 20,000 monoclonal antibodies, both recombinant and hybridoma-derived, targeting key proteins involved in cancer, neuroscience, immunology, and signal transduction pathways. Each antibody undergoes rigorous multi-pronged validation, including Western blot, immunohistochemistry, and immunofluorescence testing, and where applicable, screening against HuProt™ human proteome microarrays to confirm monospecificity. We proudly supply many of the world’s leading life science companies through OEM and private label partnerships, while continuing to expand our direct catalog offerings to researchers and pathologists worldwide. Our mission is simple: to advance scientific discovery through antibodies that work — every time. By upholding the highest standards of validation and reproducibility, NeoBiotechnologies stands as a trusted partner for the global research community seeking precision, quality, and integrity in every experiment.

Founded by Atul K. Tandon.